Monoclonal antibodies recognizing tumor-associated antigen of human ovarian mucinous cystadenocarcinomas - PubMed (original) (raw)
- PMID: 6175395
Monoclonal antibodies recognizing tumor-associated antigen of human ovarian mucinous cystadenocarcinomas
M Bhattacharya et al. Cancer Res. 1982 May.
Abstract
Spleen cells from BALB/c mice immunized with human ovarian cystadenocarcinoma extract were fused with the mouse myeloma cell line P3/NSI/1-Ag 4 in the presence of polyethylene glycol (Mr 4000). Of the 46 hybrids obtained, four secreted antibodies preferentially reactive to the immunizing ovarian tumor extract. Two of these hybrids, which showed no reaction with normal controls, were selected for cloning by the limiting dilution method. The numerous clones obtained from each hybrid were screened against a panel of five ovarian tumor extracts, pooled normal ovary extracts, and pooled normal human sera. One clone from each hybrid that showed specificity for ovarian mucinous cystadenocarcinomas was recloned to assure monoclonality and to establish a permanent hybridoma cell line. The antibodies secreted by these cell lines were of IgG1 subclass with kappa light chains. These antibody-producing hybridomas were selected for further analysis of the antibody specificity by a solid-phase radioimmunoassay and quantitative absorption tests. The monoclonal antibodies recognized an antigenic determinant present only in mucinous cystadenocarcinomas of the ovary. These did not react with any other gynecological or nongynecological tumor thus far tested. The antigen was not demonstrable in any normal adult tissues tested. Among fetal tissues examined, only fetal intestine extract showed a positive reaction. The antigenic determinant recognized by these monoclonal antibodies was unrelated to carcinoembryonic antigen, normal glycoprotein, normal human serum components, or human ABO blood group materials. These antibodies, which have relatively high affinity and can be produced in large amounts, will be useful for the isolation and immunochemical characterization of this antigen. The purified antigen and the specific antibodies could be then combined in a sensitive radioimmunoassay for the early detection of the antigen in the sera and body fluids of patients with ovarian mucinous cystadenocarcinomas.
Similar articles
- Identification of a human cancer-associated antigen defined with monoclonal antibody.
Bhattacharya M, Chatterjee SK, Barlow JJ. Bhattacharya M, et al. Cancer Res. 1984 Oct;44(10):4528-34. Cancer Res. 1984. PMID: 6380708 - Three novel mouse monoclonal antibodies, OM-A, OM-B, and OM-C, reactive with mucinous type ovarian tumors.
Sakakibara K, Ueda R, Ohta M, Nakashima N, Tomoda Y, Takahashi T. Sakakibara K, et al. Cancer Res. 1988 Aug 15;48(16):4639-45. Cancer Res. 1988. PMID: 2456145 - Monoclonal antibody against human ovarian tumor-associated antigens.
Poels LG, Peters D, van Megen Y, Vooijs GP, Verheyen RN, Willemen A, van Niekerk CC, Jap PH, Mungyer G, Kenemans P. Poels LG, et al. J Natl Cancer Inst. 1986 May;76(5):781-91. J Natl Cancer Inst. 1986. PMID: 3517452 - Production of monoclonal antibodies to bovine leukocyte cell-surface components.
Nickerson SC, Shapiro RP, Guidry AJ, Srikumaran S, Goldsby RA. Nickerson SC, et al. J Dairy Sci. 1983 Jul;66(7):1547-58. doi: 10.3168/jds.S0022-0302(83)81971-7. J Dairy Sci. 1983. PMID: 6350394 Review.
Cited by
- Generation of a High-Affinity Nanobody Against CD147 for Tumor Targeting and Therapeutic Efficacy Through Conjugating Doxorubicin.
Li R, Zhu X, Zhou P, Qiao Y, Li Y, Xu Y, Shi X. Li R, et al. Front Immunol. 2022 May 4;13:852700. doi: 10.3389/fimmu.2022.852700. eCollection 2022. Front Immunol. 2022. PMID: 35603157 Free PMC article. - Characterization of OM-B monoclonal antibody-defined antigen associated with mucinous type human ovarian tumor.
Nishida K, Ueda R, Sakakibara K, Minoura Y, Ohta M, Ariyoshi Y, Takahashi T. Nishida K, et al. Jpn J Cancer Res. 1993 Jan;84(1):65-74. doi: 10.1111/j.1349-7006.1993.tb02786.x. Jpn J Cancer Res. 1993. PMID: 8449829 Free PMC article. - Trophoblast and ovarian cancer antigen LK26. Sensitivity and specificity in immunopathology and molecular identification as a folate-binding protein.
Garin-Chesa P, Campbell I, Saigo PE, Lewis JL Jr, Old LJ, Rettig WJ. Garin-Chesa P, et al. Am J Pathol. 1993 Feb;142(2):557-67. Am J Pathol. 1993. PMID: 8434649 Free PMC article. - Cell surface antigens of human ovarian and endometrial carcinoma defined by mouse monoclonal antibodies.
Mattes MJ, Cordon-Cardo C, Lewis JL Jr, Old LJ, Lloyd KO. Mattes MJ, et al. Proc Natl Acad Sci U S A. 1984 Jan;81(2):568-72. doi: 10.1073/pnas.81.2.568. Proc Natl Acad Sci U S A. 1984. PMID: 6582512 Free PMC article. - Monoclonal antibodies to antigens associated with transitional cell carcinoma of the human urinary bladder. I. Determination of the selectivity of six antibodies by cell ELISA and immunofluorescence.
Koho H, Paulie S, Ben-Aissa H, Jónsdóttir I, Hansson Y, Lundblad ML, Perlmann P. Koho H, et al. Cancer Immunol Immunother. 1984;17(3):165-72. doi: 10.1007/BF00205481. Cancer Immunol Immunother. 1984. PMID: 6383600 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical